SCHEMBL5149264

SCHEMBL5149264

Cc1ccc(C(=O)N[C@@H](CO)Cc2c[nH]c3ccccc23)cc1-c1cccc(C(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERAP2 Q6P179 1/20 0.47
ITGB2 P05107 3/20 0.46
ICAM1 P05362 3/20 0.46
ITGAL P20701 3/20 0.46
HPGDS O60760 1/20 0.46
CCKBR P32239 1/20 0.44
POLB P06746 3/20 0.44
TACR1 P25103 3/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ECE1 P42892 1/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
HDAC8 Q9BY41 3/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155616 0.93 ERAP2 (0.47) ERAP2ITGB2ICAM1ITGALHPGDS
SCHEMBL5149376 0.90 CDK4 (0.53) ERAP2ITGB2ICAM1ITGALHPGDS
SCHEMBL5151665 0.88 HPGDS (0.58) ERAP2ITGB2ICAM1ITGALHPGDS
SCHEMBL5149438 0.88 CDK4 (0.52) ITGB2ICAM1ITGALCCKBRPOLB
SCHEMBL5149134 0.86 ERAP2 (0.48) ERAP2ITGB2ICAM1ITGALHPGDS
SCHEMBL5151626 0.84 KMT2A (0.56) ERAP2HPGDSALDH1A1MAPTHPGD
SCHEMBL5154756 0.84 ITGB2 (0.47) ERAP2ITGB2ICAM1ITGALHPGDS
SCHEMBL5154591 0.83 MEN1 (0.49) ERAP2TACR1ALDH1A1MAPTHPGD
SCHEMBL5152530 0.82 ITGB2 (0.55) ITGB2ICAM1ITGALPOLBTACR1
SCHEMBL5152074 0.82 MEN1 (0.49) ITGB2ICAM1ITGALALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R ERAP2 1644/4885ITGB2 4080/4885ICAM1 4413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.